Drug Testing | Behavioral Healthcare Magazine Skip to content Skip to navigation

Drug Testing

Opioid-related treatment approaches vary by region

June 14, 2017  |  Tom Valentino, Senior Editor
article

Data released this week by not-for-profit FAIR Health shows significant variation in treatment approaches for opioid-related diagnoses by location.

Federal agents search Sovereign Health

June 14, 2017  |  BHE Staff
news

On Tuesday, federal officials executed search warrants at several California treatment centers operated by Sovereign Health as well as its San Clemente office.

Ethics Survey: Drug testing remains a clinical tug of war

May 18, 2017  |  Julie Miller, Editor in Chief
article

Treatment centers must weigh costs and clinical needs when creating policies for patient drug testing. Meanwhile, investors are examining how drug testing fits in the greater scheme of profits and regulatory risks.

Prescription drug misuse impacting workplaces

March 16, 2017  |  Tom Valentino, Senior Editor
news

More than seven out of 10 employers surveyed say their workplaces have been impacted by the misuse of prescription drugs, according to the National Safety Council.

Ethics Survey: Behavioral health leaders examine industry conduct

March 1, 2017  |  Julie Miller, Editor in Chief
article

It’s difficult to quantify the prevalence of unethical practices in behavioral health, but most agree it's more a case of criminal enterprise than treatment centers gone bad. See the survey results with expert analysis.

ASAM seeks input on appropriate drug testing

February 10, 2017  |  Tom Valentino, Senior Editor
article

ASAM is accepting public comment on a drug testing appropriateness document that is being developed to provide guidance on drug testing in diagnosis, treatment and promotion of recovery from addiction.

Florida poised to turn the corner on unethical practices in 2017

January 4, 2017  |  Gary A. Enos
article

There are signs that Florida legislators might finally enact tough measures to curb unethical behavior among notorious addiction treatment and sober home operators.

Kratom research sorely needed for clinical, policy decisions

October 13, 2016  |  Julie Miller, Editor in Chief
article

In response to advocacy groups and congressional leaders, the Drug Enforcement Administration halted its attempt to place kratom on the list of Schedule I drugs, however, experts recommend more research on its pharmacology moving forward.

Claims study quantifies growing impact of opioid crisis

September 13, 2016  |  Julie Miller, Editor in Chief
article

Commercial health insurers paid treatment centers and other providers $445.7 million to treat plan members’ opioid dependence and abuse in 2015, demonstrating a 1,375% spending increase over five years.

Insurer drops drug screen requirement for hep C coverage

September 13, 2016  |  Tom Valentino, Senior Editor
news

As part of a $300 million settlement, UnitedHealthcare will no longer require policyholders to demonstrate abstinence from drugs and alcohol for six months before receiving coverage for a costly hepatitis C medication.

UnitedHealth names labs, treatment centers in federal fraud case

May 2, 2016  |  Julie Miller, Editor in Chief
article

UnitedHealth and its Florida affiliate filed a $50 million federal lawsuit against several testing labs, treatment centers and individuals, alleging financial kickbacks, fraud and other complaints.

New group funds patient copays for treatment

April 13, 2016  |  Julie Miller, Editor in Chief
article

The new not-for-profit Insured Consumer Access Network (ICAN) will provide scholarships for patients' out-of-pocket costs for treatment within a network of ethical providers.

Pages

Subscribe to Drug Testing